Meta-Analysis
Copyright ©The Author(s) 2019.
World J Clin Oncol. Jun 24, 2019; 10(6): 234-246
Published online Jun 24, 2019. doi: 10.5306/wjco.v10.i6.234
Table 1 Characteristics of the included studies
StudyYOPPatients, M/F/TSOX2 expression, high/lowClinical stage, I+II/ III +IVCancer typeOutcomesSurvival analysisNOS
Abd El-Maqsoud et al[10]20140/126/12642/84NAIBCLNMNA7
Chen et al[26]201659/18/7728/4926/51GCDM, LNM, OSMu8
Chen et al[27]2016233/74/30796/21195/212GCDM, LNMNA8
Chuang et al[14]201572/3/7540/3521/27ESCCDM, LNMNA6
Dai et al[17]201475/56/13182/4977/54ACCDM, OS, DFSMu7
Ge et al[18]201084/1/8567/1821/64HSCCLNM, OS, DFSMu7
González-Márquez et al[19]2014203/17/22074/14624/196SCCDM, LNM, OS, DFSMu6
Liu et al[23]201835/26/6139/2246/15TSCCDM, LNM, OSMu7
Liu et al[11]20180/237/237122/115167/70BCLNMNA7
Luo et al[20]201392/30/12268/5433/89NPCDM, LNM, OSMu6
Neumann et al[13]201158/56/11424/90NACCDM, LNMNA7
Saigusa et al[15]201118/2/208/1210/10ESCCLNM, OSU7
Shen et al[12]20140/132/13283/4970/62CSCCDM, OSMu8
Sun et al[24]201365/10/7546/29NAHCCDM, LNMNA6
Tang et al[21]2013152/9/16188/7365/96LSCCLNM, OSMu8
Wang et al[16]201887/30/11754/6348/69ESCCLNM, OSMu7
Wang et al[28]2015132/71/20348/15565/138GCLNMNA6
Yang et al[25]2013140/82/222124/98173/49SCLCLNMNA7
Yoshihama et al[22]201669/39/10863/4564/44OSCCDM, LNM, OSMu7
Zhang et al[29]201035/15/5016/3431/19GCLNMNA6